ResearcherKindai UniversityActive in the last 2 years
Suman Dash
Matched on ORCID iD 0000-0003-3290-1607; OpenAlex author ID A5061806000. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 1
2023: 1 paper · 2024: 2 papers
Papers 3
- Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Co-author DOI 10.1038/s41419-024-06531-x↗
- Correction: Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer. Co-author DOI 10.1038/s41419-024-06628-3↗
- MYC/Glutamine Dependency Is a Therapeutic Vulnerability in Pancreatic Cancer with Deoxycytidine Kinase Inactivation-Induced Gemcitabine Resistance. Co-author DOI 10.1158/1541-7786.mcr-22-0554↗
Closest collaborators
The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hitoshi Okada · 3 shared papers, 2023–2024 · strength 0.72
- Paper Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference … DOI 10.1038/s41419-024-06531-x↗
- Paper Correction: Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism i… DOI 10.1038/s41419-024-06628-3↗
- Paper MYC/Glutamine Dependency Is a Therapeutic Vulnerability in Pancreatic Cancer with Deoxycytidine Kinase Inactivation-Ind… DOI 10.1158/1541-7786.mcr-22-0554↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.